Evidence map›Paper›PMID 37151430›Full record

ArticleSurgical neurology international2023

Telovelar versus transvermian approach to tumors of the fourth ventricle and their impact on postoperative neurological complications: A multicenter study.

Samuel D Pettersson, Redwan Jabbar, Mirosława Popławska, Aleksander Och, Eduardo Orrego-Gonzalez, Tomasz Klepinowski, Michał Krakowiak, Leszek Sagan, Maciej Radek, Krzysztof Zakrzewski and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Surgical neurology international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Samuel D PetterssonDepartment of Neurosurgery, Medical University of Gdansk, Gdansk, Poland.
Redwan JabbarDepartment of Neurosurgery, Medical University of Lodz, Lodz, Poland.
Mirosława PopławskaInstitute of Medicine, Opole University, Opole, Poland.
Aleksander OchDepartment of Neurosurgery, Medical University of Gdansk, Gdansk, Poland.
Eduardo Orrego-GonzalezDivision of Neurosurgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, United States.
Tomasz KlepinowskiDepartment of Neurosurgery, Pomeranian Medical University, Szczecin.
Michał KrakowiakDepartment of Neurosurgery, Medical University of Gdansk, Gdansk, Poland.
Leszek SaganDepartment of Neurosurgery, Pomeranian Medical University, Szczecin.
Maciej RadekDepartment of Neurosurgery, Medical University of Lodz, Lodz, Poland.
Krzysztof ZakrzewskiDepartment of Neurosurgery, Polish Mother Memorial Research Institute, Poland.
Emilia NowoslawskaDepartment of Neurosurgery, Polish Mother Memorial Research Institute, Poland.
Katarzyna KwiecienDepartment of Neurosurgery and Neuro-oncology, Medical University of Lodz, Lodz, Poland.
Paulina SkrzypkowskaDepartment of Neurosurgery, Medical University of Gdansk, Gdansk, Poland.
Tomasz SzmudaDepartment of Neurosurgery, Medical University of Gdansk, Gdansk, Poland.
Grzegorz MiękisiakInstitute of Medicine, Opole University, Opole, Poland.
Rafael A VegaDivision of Neurosurgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, United States.
Gdańsk Medical University · PLMedical University of Lodz · PLHarvard University · USPolish Mother’s Memorial Hospital Research Institute · PLPomeranian Medical University · PLUniversity of Opole · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Tumors of the fourth ventricle are exceedingly rare; however, such lesions are formidable due to the severe postoperative neurological complications (pNCs) which often occur. The adoption of the telovelar approach over the transvermian was created to supposedly mitigate the pNCs; however, there is a lack of sufficient data supporting this theory. Methods: Records from six hospitals were reviewed for patients surgically treated for a single tumor within the 4 Results: This study of 67 patients confirms no significant differences in risk for pNCs between the transvermian and telovelar approach. Rather, multivariate analysis identified neurophysiological monitoring (IONM) as a protective factor for postoperative speech and swallowing defects (odds ratio [OR]: 0.076, 95% confidence interval [CI] 0.011-0.525). Furthermore, intraoperative external ventricular drainage (EVD) was a protective factor for postoperative gait and focal motor defects (OR: 0.075, 95% CI 0.009-0.648) and for postoperative hydrocephalus (OR: 0.020, 95% CI 0.002-0.233). A univariate meta-analysis pooling the present study's patients and an additional 304 patients from the three additional studies in the literature confirms no significant differences in risk between the transvermian and telovelar approach for pNCs. Conclusion: Intraoperative adjuncts including IONM and EVD may play a significant role in the postoperative outcome. Despite the present study's sample size being a major limitation, the findings may provide great value to neurosurgeons given the scarcity of the current literature.

Indexed as

ComplicationsFourth ventricleTelovelarTransvermianTumor

Identifiers

PMID37151430
PMCPMC10159312
OpenAlexW4362701139

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.